Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 14/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79938 | 0.84 | ACHE (0.34) | KDM4E | |
| SCHEMBL29043134 | 0.83 | KDM4E (0.35) | KDM4E | |
| SCHEMBL27780836 | 0.81 | CYP1A2 (0.47) | EPHX2CYP1A2CYP3A4CYP2C19SMN1; SMN2 | |
| SCHEMBL9323713 | 0.80 | GAA (0.46) | DGKAMAPTALDH1A1HPGD | |
| SCHEMBL176417 | 0.80 | DGKA (0.42) | EPHX2DGKACYP1A2MAPTALDH1A1 | |
| SCHEMBL19528803 | 0.79 | CYP1A2 (0.44) | EPHX2CYP1A2CYP3A4CYP2C19SMN1; SMN2 | |
| SCHEMBL8839165 | 0.78 | DGKA (0.52) | EPHX2DGKACYP1A2MAPTALDH1A1 | |
| SCHEMBL29440665 | 0.78 | THRB (0.35) | ALDH1A1 | |
| SCHEMBL16754905 | 0.77 | ACHE (0.32) | ALDH1A1 | |
| SCHEMBL10081657 | 0.77 | ALDH1A1 (0.50) | EPHX2DGKACYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210052469-A1 | POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES | VOCO GMBH (DE) | 2021-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210052469-A1 | POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES | NCAPH, RCC1, NCAPD2 | EPHX2 923/4885DGKA 2791/4885CYP1A2 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.